D&D Pharmatech (347850.KQ)

KRW 47200.0

(0.21%)

Net Income Summary of D&D Pharmatech

D&D Pharmatech's latest annual net income in 2023 was 3.93 Billion KRW , up 102.89% from previous year.
D&D Pharmatech's latest quarterly net income in 2024 Q2 was -5.78 Billion KRW , down -2.98% from previous quarter.
D&D Pharmatech reported an annual net income of -136.06 Billion KRW in 2022, down -99.44% from previous year.
D&D Pharmatech reported an annual net income of -68.22 Billion KRW in 2021, down -7.6% from previous year.
D&D Pharmatech reported a quarterly net income of -5.61 Billion KRW for 2024 Q1, down -1197.42% from previous quarter.
D&D Pharmatech reported a quarterly net income of 511.86 Million KRW for 2023 Q4, up 192.92% from previous quarter.

Annual Net Income Chart of D&D Pharmatech (2023 - 2019)

Historical Annual Net Income of D&D Pharmatech (2023 - 2019)

Year	Net Income	Net Income Growth
2023	3.93 Billion KRW	102.89%
2022	-136.06 Billion KRW	-99.44%
2021	-68.22 Billion KRW	-7.6%
2020	-63.4 Billion KRW	-897.09%
2019	-6.35 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-5.78 Billion KRW	-2.98%
2024 Q1	-5.61 Billion KRW	-1197.42%
2023 Q4	511.86 Million KRW	192.92%
2023 FY	3.93 Billion KRW	102.89%
2023 Q3	174.74 Million KRW	-99.01%
2023 Q2	17.58 Billion KRW	983.22%
2023 Q1	1.62 Billion KRW	101.73%
2022 FY	-136.06 Billion KRW	-99.44%
2022 Q4	-93.94 Billion KRW	0.0%
2021 FY	-68.22 Billion KRW	-7.6%
2020 FY	-63.4 Billion KRW	-897.09%
2019 FY	-6.35 Billion KRW	0.0%

Peer Net Income Comparison of D&D Pharmatech

Name	Net Income	Net Income Difference
HLB Co., Ltd.	-189.07 Billion KRW	102.081%
iNtRON Biotechnology, Inc.	-9.69 Billion KRW	140.574%
BINEX Co., Ltd.	4.67 Billion KRW	15.778%
Bioneer Corporation	-10.58 Billion KRW	137.157%
Anterogen.Co.,Ltd.	-2.84 Billion KRW	238.473%
MEDIPOST Co., Ltd.	5.83 Billion KRW	32.64%
CrystalGenomics, Inc.	-48.92 Billion KRW	108.041%
Helixmith Co., Ltd	-64.08 Billion KRW	106.138%
Chabiotech Co.,Ltd.	-8.43 Billion KRW	146.657%
Medy-Tox Inc.	9.75 Billion KRW	59.674%
Peptron, Inc.	-15.92 Billion KRW	124.707%
Amicogen, Inc.	-23.28 Billion KRW	116.891%
Genexine, Inc.	-66.87 Billion KRW	105.882%
HLB Therapeutics Co.,Ltd.	-2.3 Billion KRW	270.875%
LegoChem Biosciences, Inc.	-73.7 Billion KRW	105.337%
ALTEOGEN Inc.	-3.37 Billion KRW	216.669%
PharmaResearch Co., Ltd.	76.55 Billion KRW	94.861%
SillaJen, Inc.	-20.36 Billion KRW	119.312%
JETEMA, Co., Ltd.	13.96 Billion KRW	71.833%
OliX Pharmaceuticals,Inc	-19.1 Billion KRW	120.594%
Genomictree Inc.	-8.75 Billion KRW	144.927%
MedPacto, Inc.	-35.32 Billion KRW	111.136%
EASY BIO,Inc.	15.54 Billion KRW	74.692%
GI Innovation, Inc.	-55.49 Billion KRW	107.089%